Table: Pharmarise Holdings -2022/23 group results

Pharmarise Holdings

11/07/2023 09:30

Jul 11 (Reuters)- 
          Pharmarise Holdings Corp 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT    
                May 31, 2023    May 31, 2022   May 31, 2024     YEAR      
                   LATEST         YEAR-AGO        COMPANY       COMPANY   
                   RESULTS         RESULTS       FORECAST     H1 FORECAST 
  Sales             52.03           51.61          53.55         26.56    
                 (+0.8 pct)      (-1.4 pct)     (+2.9 pct)    (+3.2 pct)  
  Operating          1.44            1.52           1.48        833 mln   
                 (-5.4 pct)      (+22.0 pct)    (+2.7 pct)    (+45.4 pct) 
  Recurring          1.43            1.52           1.42        803 mln   
                 (-5.7 pct)      (+17.7 pct)    (-0.6 pct)    (+41.9 pct) 
  Net
  Net              333 mln         447 mln        449 mln       262 mln   
                 (-25.6 pct)     (+5.0 pct)     (+34.9 pct)  (+260.8 pct) 
  EPS             35.45 yen       47.99 yen      46.14 yen     26.92 yen  
  EPS Diluted     26.90 yen       36.29 yen                               
  Ann Div         14.00 yen       14.00 yen      20.00 yen                
  -Q2 Div            NIL             NIL            NIL                   
  -Q4 Div         14.00 yen       14.00 yen      20.00 yen                
  
  NOTE - Pharmarise Holdings Corp.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T